NON-DISCLOSURE AND CONFIDENTIALITY AGREEMENTNon-Disclosure and Confidentiality Agreement • March 2nd, 2007 • Shuttle Corp • Pharmaceutical preparations • Virginia
This Non-Disclosure AND Confidentiality Agreement (hereinafter the “Agreement”) is made and entered into as of the 16th day of July, 2002 (hereinafter “Effective Date”), by and between Shire US Inc. (hereinafter “SHIRE”), and New River Pharmaceuticals Inc. (formerly, Lotus Biochemical Corporation), a Virginia corporation with offices located at The Governor Tyler, 1902 Downey Street, Radford, Virginia 24141 (hereinafter “NEW RIVER”) (each individually hereinafter referred to as a “Party” and collectively referred to as “Parties”).
CONTENTSFacilities Agreement • March 2nd, 2007 • Shuttle Corp • Pharmaceutical preparations
NON- DISCLOSURE & CONFIDENTIALITY AGREEMENTNon-Disclosure & Confidentiality Agreement • March 2nd, 2007 • Shuttle Corp • Pharmaceutical preparations • New York
This Non-Disclosure & Confidentiality Agreement (hereinafter this “Agreement”) is made and entered into as of the 28th day of November, 2006 (hereinafter “Effective Date”), by and between Shire Pharmaceuticals, Inc., a Delaware corporation having a principal place of business at 725 Chesterbrook Boulevard, Wayne, PA 19087 (“SHIRE”), L.E.K. Consulting LLC, 28 State Street, 16th Floor, Boston, Massachusetts 02109 (“L.E.K.”), and New River Pharmaceuticals Inc., a Virginia corporation with offices located at The Governor Tyler, 1881 Grove Avenue, Radford, Virginia 24141 (“NEW RIVER”) (each individually hereinafter referred to as a “Party” and collectively referred to as “Parties”).
